Assets, Current in USD of BioAge Labs, Inc. from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
BioAge Labs, Inc. quarterly Assets, Current history and growth rate from Q4 2023 to Q3 2025.
  • BioAge Labs, Inc. Assets, Current for the quarter ending September 30, 2025 was $291M, a 13.6% decline year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)

BioAge Labs, Inc. Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $291M -$45.6M -13.6% Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $302M Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $325M Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $357M +$332M +1311% Dec 31, 2024 10-Q 2025-11-06
Q3 2024 $336M Sep 30, 2024 10-Q 2024-11-07
Q4 2023 $25.3M Dec 31, 2023 10-K 2025-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.